CCL5 and familial pancreatic carcinoma: Chen et al. reported that the CCL5‐SDC1/4 interaction between T cells and tumor cells can promote pancreatic cancer metastasis47 and the monoclonal antibody SDC1 against pancreatic cancer is being actively developed.48